NCT00617799 2023-10-10
Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
Completed
University of Nebraska
SWOG Cancer Research Network
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)